-
2
-
-
0021288105
-
2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure
-
2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure. Pharmacol. Ther. 24:1984;165-177.
-
(1984)
Pharmacol. Ther.
, vol.24
, pp. 165-177
-
-
Baumann, G.1
Permanetter, B.2
Wirtzfeld, A.3
-
4
-
-
0023186316
-
Arylmethylthioalkylguanidin-Derivate, Synthese und pharmakologische Wirkung
-
Buschauer A. Arylmethylthioalkylguanidin-Derivate, Synthese und pharmakologische Wirkung. Arzneim.-Forsch. 37:1987;1008-1012.
-
(1987)
Arzneim.-Forsch.
, vol.37
, pp. 1008-1012
-
-
Buschauer, A.1
-
5
-
-
0023831630
-
Phenoxy- and phenylthioalkylguanidines - Synthesis and in vitro pharmacology
-
Buschauer A. Phenoxy- and phenylthioalkylguanidines - synthesis and in vitro pharmacology. Eur. J. Med. Chem. 23:1988;1-6.
-
(1988)
Eur. J. Med. Chem.
, vol.23
, pp. 1-6
-
-
Buschauer, A.1
-
6
-
-
0024046338
-
Synthese positiv inotroper Substanzen: Imidazolylpropylguanidine mit Pyridin-Partialstruktur
-
Buschauer A. Synthese positiv inotroper Substanzen: Imidazolylpropylguanidine mit Pyridin-Partialstruktur. Arch. Pharm. (Weinheim). 321:1988;415-418.
-
(1988)
Arch. Pharm. (Weinheim)
, vol.321
, pp. 415-418
-
-
Buschauer, A.1
-
7
-
-
0024327023
-
Synthesis and in vitro pharmacology of arpromidine and related phenylpyridylalkylguanidines, a potential new class of positive inotropic drugs
-
Buschauer A. Synthesis and in vitro pharmacology of arpromidine and related phenylpyridylalkylguanidines, a potential new class of positive inotropic drugs. J. Med. Chem. 32:1989;1963-1970.
-
(1989)
J. Med. Chem.
, vol.32
, pp. 1963-1970
-
-
Buschauer, A.1
-
8
-
-
0025775482
-
2-agonists, a new class of positive inotropic drugs
-
Timmerman, H., van der Goot, H. (Eds.), Birkhäuser Verlag, Basel
-
2-agonists, a new class of positive inotropic drugs. In: Timmerman, H., van der Goot, H. (Eds.), New Perspectives in Histamine Research, Agents Actions Suppl. 33, Birkhäuser Verlag, Basel, pp. 231-256.
-
(1991)
New Perspectives in Histamine Research, Agents Actions
, Issue.SUPPL. 33
, pp. 231-256
-
-
Buschauer, A.1
Baumann, G.2
-
9
-
-
0026762919
-
2 agonistic activity of arpromidine analogues: Replacement of the pheniramine-like moiety by non-heterocyclic groups
-
2 agonistic activity of arpromidine analogues: replacement of the pheniramine-like moiety by non-heterocyclic groups. Eur. J. Med. Chem. 27:1992;321-330.
-
(1992)
Eur. J. Med. Chem.
, vol.27
, pp. 321-330
-
-
Buschauer, A.1
Friese-Kimmel, A.2
Baumann, G.3
Schunack, W.4
-
10
-
-
0026358003
-
2-agonistic activity of ring-substituted phenyl analogues of impromidine
-
2-agonistic activity of ring-substituted phenyl analogues of impromidine. Pharmazie. 46:1991;841-845.
-
(1991)
Pharmazie
, vol.46
, pp. 841-845
-
-
Buschauer, A.1
Lachenmayr, F.2
Schunack, W.3
-
11
-
-
0023751431
-
Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins
-
Cramer R.D. III, Patterson D.E., Bunce J.D. Comparative molecular field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110:1988;5959-5967.
-
(1988)
J. Am. Chem. Soc.
, vol.110
, pp. 5959-5967
-
-
Cramer R.D. III1
Patterson, D.E.2
Bunce, J.D.3
-
13
-
-
0024242801
-
Halogenderivate von N-[3-(Imidazol-4-yl)propyl]-N′-(2-phenylthioalkyl)guanidinen
-
Elz S., Kimmel U., Buschauer A., Schunack W. Halogenderivate von N-[3-(Imidazol-4-yl)propyl]-N′-(2-phenylthioalkyl)guanidinen. Sci. Pharm. 56:1988;229-234.
-
(1988)
Sci. Pharm.
, vol.56
, pp. 229-234
-
-
Elz, S.1
Kimmel, U.2
Buschauer, A.3
Schunack, W.4
-
14
-
-
0002165646
-
CoMFA - Scope and limitations
-
Kubinyi, H. (Ed.), ESCOM Sci. Publ., Leiden
-
Folkers, G., Merz, A., Rognan, D., 1993. CoMFA - scope and limitations. In: Kubinyi, H. (Ed.), 3D-QSAR in Drug Design - Theory, Methods and Applications. ESCOM Sci. Publ., Leiden, pp. 583-618.
-
(1993)
3D-QSAR in Drug Design - Theory, Methods and Applications
, pp. 583-618
-
-
Folkers, G.1
Merz, A.2
Rognan, D.3
-
15
-
-
0026802096
-
2-agonists related to impromidine and arpromidine
-
2-agonists related to impromidine and arpromidine. Eur. J. Med. Chem. 27:1992;443-448.
-
(1992)
Eur. J. Med. Chem.
, vol.27
, pp. 443-448
-
-
Franke, R.1
Buschauer, A.2
-
16
-
-
0026644846
-
2 receptor
-
2 receptor. J. Biol. Chem. 267:1992;20840-20843.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 20840-20843
-
-
Gantz, I.1
Del Valle, J.2
Wang, L.D.3
Tashiro, T.4
Muntzert, G.5
Guo, Y.J.6
Konda, Y.7
Yamada, T.8
-
18
-
-
0001191266
-
Exploring QSAR. Hydrophobic, electronic, and steric constants
-
Washington, DC
-
Hansch, C., Leo, A., Hoekman, D., 1995. Exploring QSAR. Hydrophobic, electronic, and steric constants. Am. Chem. Soc. Prof. Ref. Book, Washington, DC.
-
(1995)
Am. Chem. Soc. Prof. Ref. Book
-
-
Hansch, C.1
Leo, A.2
Hoekman, D.3
-
19
-
-
0017895991
-
Histamine analogues: XVI. Synthesis and action of 5-alkyl substituted histamines and Nα-methylhistamines
-
Lennartz H.-G., Hepp M., Schunack W. Histamine analogues: XVI. Synthesis and action of 5-alkyl substituted histamines and Nα-methylhistamines. Eur. J. Med. Chem. 13:1978;229-234.
-
(1978)
Eur. J. Med. Chem.
, vol.13
, pp. 229-234
-
-
Lennartz, H.-G.1
Hepp, M.2
Schunack, W.3
-
22
-
-
0026660322
-
Modeling of G-protein-coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors
-
Trumpp-Kallmeyer S., Hoflack J., Bruinvels A., Hibert M. Modeling of G-protein-coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 35:1992;3448-3462.
-
(1992)
J. Med. Chem.
, vol.35
, pp. 3448-3462
-
-
Trumpp-Kallmeyer, S.1
Hoflack, J.2
Bruinvels, A.3
Hibert, M.4
-
23
-
-
0000295654
-
PLS for multivariate linear modeling
-
Van der Waterbeemd, H. (Ed.), Verlag Chemie, Weinheim
-
Wold, S., 1995. PLS for multivariate linear modeling. In: Van der Waterbeemd, H. (Ed.), Chemometric Methods in Drug Design, Methods and Principles in Medicinal Chemistry, Vol. 2. Verlag Chemie, Weinheim, pp. 195-218.
-
(1995)
Chemometric Methods in Drug Design, Methods and Principles in Medicinal Chemistry
, vol.2
, pp. 195-218
-
-
Wold, S.1
|